Loading clinical trials...
Loading clinical trials...
The purpose of this study is to understand the role of a specific protein, tumor protein p63 in the skin disease psoriasis. This study is to further understand how psoriasis lesions happens. An understanding of key mediators that lead to psoriasis might aid in the discovery of more effective treatments for this skin disorder. This is not an intervention study. The study is looking to obtain currently untreated plaque psoriasis biopsies and also biopsies from non psoriasis patients. Psoriasis and medical history will be collected then skin biopsies will be obtained from the subjects.
Age
18 - 50 years
Sex
ALL
Healthy Volunteers
No
Wright State Physicians
Fairborn, Ohio, United States
Start Date
December 3, 2020
Primary Completion Date
April 14, 2023
Completion Date
April 14, 2023
Last Updated
April 21, 2023
9
ACTUAL participants
No intervention - Psoriasis Subject
OTHER
No intervention - Control Subject
OTHER
Lead Sponsor
Wright State University
NCT07449234
NCT07116967
NCT07250802
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions